The present invention relates to substituted xanthines of general formula
wherein R
1
to R
3
are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
本发明涉及一般式的取代
黄嘌呤,其中R1至R3如本文所定义,其互变异构体、立体异构体、混合物、前药和盐具有有价值的药理特性,特别是对酶二肽基肽酶-IV(
DPP-IV)的活性有抑制作用。